Enzymatic degradation of neuropeptide FF and SQA-neuropeptide FF in the mouse brain

被引：12
作者：
Sol, JC [1 ]
Roussin, A [1 ]
Proto, S [1 ]
Mazarguil, H [1 ]
Zajac, JM [1 ]
机构：
[1] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
来源：
PEPTIDES | 1999年 / 20卷 / 10期
关键词：
neuropeptide FF; SQA-neuropeptide FF; degradation; peptidases; brain slices; mouse; capillary electrophoresis;
D O I：
10.1016/S0196-9781(99)00126-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Degradation of neuropeptide FF (NPFF) and SQA-neuropeptide FF (SQA-NPFF) by mouse brain sections was investigated by using capillary electrophoresis with UV detection for the separation and the identification of the degradation products. The half disappearance time of SQA-NPFF was 2-fold greater than that of NPFF. NPFF was cleaved preferentially into an inactive metabolite, Gln-Arg-Phe-NH,, in the cerebrum slices. SQA-NPFF was hydrolyzed by an unidentified degrading activity to generate NPFF, and NPFF accounted for a larger part of SQA-NPFF degradation in the hindbrain and cervical spinal cord than in the cerebrum slices. These findings suggest that, depending on the brain regions, NPFF produced from SQA-NPFF could prolong the biologic effects of SQA-NPFF. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码：1219 / 1227
页数：9
相关论文
共 50 条
  • [41] Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs
    Quelven, I
    Roussin, A
    Burlet-Schiltz, O
    Gouardères, C
    Tafani, JAM
    Mazarguil, H
    Zajac, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (1-2) : 91 - 98
  • [42] Neuropeptide FF in the rat adrenal gland: Presence, distribution and pharmacological effects
    Labrouche, S
    Laulin, JP
    Le Moal, M
    Tramu, G
    Simonnet, G
    JOURNAL OF NEUROENDOCRINOLOGY, 1998, 10 (07) : 559 - 565
  • [43] Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area
    Kersante, Flavie
    Wang, Jin-Ya
    Chen, Jin-Chung
    Mollereau, Catherine
    Zajac, Jean-Marie
    NEUROSCIENCE LETTERS, 2011, 488 (03) : 305 - 309
  • [44] IGG FROM NEUROPEPTIDE FF ANTISERUM REVERSES MORPHINE-TOLERANCE IN THE RAT
    LAKE, JR
    HAMMOND, MV
    SHADDOX, RC
    HUNSICKER, LM
    YANG, HYT
    MALIN, DH
    NEUROSCIENCE LETTERS, 1991, 132 (01) : 29 - 32
  • [45] Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide
    Gelot, A
    Mazarguil, H
    Dupuy, P
    Francés, B
    Gouardères, C
    Roumy, M
    Zajac, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) : 167 - 172
  • [46] Comparison of serum neuropeptide-FF and catestatin levels in hypertensive pregnant women
    Gunsel, Hamdin
    Oruc, Semra
    Taneli, Fatma
    Sizer, Mulaim
    Kirteke, Kenan
    Sunar, Nebahat
    Okuyan, Erhan
    Yoldas, Adem
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (07): : 495 - 499
  • [47] Fluorescence polarization assays for high-throughput screening of neuropeptide FF receptors
    Do, EU
    Choi, G
    Shin, J
    Jung, WS
    Kim, SI
    ANALYTICAL BIOCHEMISTRY, 2004, 330 (01) : 156 - 163
  • [48] Identification and Functional Characterization of the Phosphorylation Sites of the Neuropeptide FF2 Receptor
    Bray, Lauriane
    Froment, Carine
    Pardo, Pierre
    Candotto, Cedric
    Burlet-Schiltz, Odile
    Zajac, Jean-Marie
    Mollereau, Catherine
    Mouledous, Lionel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (49) : 33754 - 33766
  • [49] Vasopressin (VP) and Neuropeptide FF (NPFF) Systems in the Normal and Hypertensive Human Brainstem
    Goncharuk, Valeri D.
    Buijs, Ruud M.
    Jhamandas, Jack H.
    Swaab, Dick F.
    JOURNAL OF COMPARATIVE NEUROLOGY, 2011, 519 (01) : 93 - 124
  • [50] Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs
    Gouardères, C
    Sutak, M
    Zajac, JM
    Jhamandas, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) : 391 - 401
12345